144 related articles for article (PubMed ID: 8662678)
1. Modification of the pH profile and tetrabenazine sensitivity of rat VMAT1 by replacement of aspartate 404 with glutamate.
Steiner-Mordoch S; Shirvan A; Schuldiner S
J Biol Chem; 1996 May; 271(22):13048-54. PubMed ID: 8662678
[TBL] [Abstract][Full Text] [Related]
2. Histidine-419 plays a role in energy coupling in the vesicular monoamine transporter from rat.
Shirvan A; Laskar O; Steiner-Mordoch S; Schuldiner S
FEBS Lett; 1994 Dec; 356(1):145-50. PubMed ID: 7988710
[TBL] [Abstract][Full Text] [Related]
3. Individual residues contribute to multiple differences in ligand recognition between vesicular monoamine transporters 1 and 2.
Finn JP; Edwards RH
J Biol Chem; 1997 Jun; 272(26):16301-7. PubMed ID: 9195934
[TBL] [Abstract][Full Text] [Related]
4. Identification of residues involved in substrate recognition by a vesicular monoamine transporter.
Merickel A; Rosandich P; Peter D; Edwards RH
J Biol Chem; 1995 Oct; 270(43):25798-804. PubMed ID: 7592763
[TBL] [Abstract][Full Text] [Related]
5. Multiple residues contribute independently to differences in ligand recognition between vesicular monoamine transporters 1 and 2.
Finn JP; Edwards RH
J Biol Chem; 1998 Feb; 273(7):3943-7. PubMed ID: 9461580
[TBL] [Abstract][Full Text] [Related]
6. Chimeric vesicular monoamine transporters identify structural domains that influence substrate affinity and sensitivity to tetrabenazine.
Peter D; Vu T; Edwards RH
J Biol Chem; 1996 Feb; 271(6):2979-86. PubMed ID: 8621690
[TBL] [Abstract][Full Text] [Related]
7. Charged residues in transmembrane domains II and XI of a vesicular monoamine transporter form a charge pair that promotes high affinity substrate recognition.
Merickel A; Kaback HR; Edwards RH
J Biol Chem; 1997 Feb; 272(9):5403-8. PubMed ID: 9038139
[TBL] [Abstract][Full Text] [Related]
8. Lobeline analogs with enhanced affinity and selectivity for plasmalemma and vesicular monoamine transporters.
Miller DK; Crooks PA; Zheng G; Grinevich VP; Norrholm SD; Dwoskin LP
J Pharmacol Exp Ther; 2004 Sep; 310(3):1035-45. PubMed ID: 15121762
[TBL] [Abstract][Full Text] [Related]
9. Cloning and functional expression of a tetrabenazine sensitive vesicular monoamine transporter from bovine chromaffin granules.
Howell M; Shirvan A; Stern-Bach Y; Steiner-Mordoch S; Strasser JE; Dean GE; Schuldiner S
FEBS Lett; 1994 Jan; 338(1):16-22. PubMed ID: 8307150
[TBL] [Abstract][Full Text] [Related]
10. Expression cloning of a reserpine-sensitive vesicular monoamine transporter.
Erickson JD; Eiden LE; Hoffman BJ
Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10993-7. PubMed ID: 1438304
[TBL] [Abstract][Full Text] [Related]
11. Biochemistry and molecular biology of the vesicular monoamine transporter from chromaffin granules.
Henry JP; Botton D; Sagne C; Isambert MF; Desnos C; Blanchard V; Raisman-Vozari R; Krejci E; Massoulie J; Gasnier B
J Exp Biol; 1994 Nov; 196():251-62. PubMed ID: 7823026
[TBL] [Abstract][Full Text] [Related]
12. Distinct pharmacological properties and distribution in neurons and endocrine cells of two isoforms of the human vesicular monoamine transporter.
Erickson JD; Schafer MK; Bonner TI; Eiden LE; Weihe E
Proc Natl Acad Sci U S A; 1996 May; 93(10):5166-71. PubMed ID: 8643547
[TBL] [Abstract][Full Text] [Related]
13. Reserpine- and tetrabenazine-sensitive transport of (3)H-histamine by the neuronal isoform of the vesicular monoamine transporter.
Erickson JD; Eiden LE; Schafer MK; Weihe E
J Mol Neurosci; 1995; 6(4):277-87. PubMed ID: 8860238
[TBL] [Abstract][Full Text] [Related]
14. A chimeric vesicular monoamine transporter dissociates sensitivity to tetrabenazine and unsubstituted aromatic amines.
Erickson JD
Adv Pharmacol; 1998; 42():227-32. PubMed ID: 9327885
[No Abstract] [Full Text] [Related]
15. The photoactivatable inhibitor 7-azido-8-iodoketanserin labels the N terminus of the vesicular monoamine transporter from bovine chromaffin granules.
Sagné C; Isambert MF; Vandekerckhove J; Henry JP; Gasnier B
Biochemistry; 1997 Mar; 36(11):3345-52. PubMed ID: 9116013
[TBL] [Abstract][Full Text] [Related]
16. Characterization of high-affinity [3H]TBZOH binding to the human platelet vesicular monoamine transporter.
Zucker M; Weizman A; Rehavi M
Life Sci; 2001 Sep; 69(19):2311-7. PubMed ID: 11669473
[TBL] [Abstract][Full Text] [Related]
17. Transport of histamine by vesicular monoamine transporter-2.
Merickel A; Edwards RH
Neuropharmacology; 1995 Nov; 34(11):1543-7. PubMed ID: 8606801
[TBL] [Abstract][Full Text] [Related]
18. Functional identification and molecular cloning of a human brain vesicle monoamine transporter.
Erickson JD; Eiden LE
J Neurochem; 1993 Dec; 61(6):2314-7. PubMed ID: 8245983
[TBL] [Abstract][Full Text] [Related]
19. The pharmacological profile of the vesicular monoamine transporter resembles that of multidrug transporters.
Yelin R; Schuldiner S
FEBS Lett; 1995 Dec; 377(2):201-7. PubMed ID: 8543051
[TBL] [Abstract][Full Text] [Related]
20. Vesicular monoamine transport inhibitors. Novel action at calcium channels to prevent catecholamine secretion.
Mahata M; Mahata SK; Parmer RJ; O'Connor DT
Hypertension; 1996 Sep; 28(3):414-20. PubMed ID: 8794826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
